Manufacturing - Textiles
Compare Stocks
5 / 10Stock Comparison
MAGN vs AVNT vs SON vs EMN vs LYB
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals - Specialty
Packaging & Containers
Chemicals - Specialty
Chemicals - Specialty
MAGN vs AVNT vs SON vs EMN vs LYB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Manufacturing - Textiles | Chemicals - Specialty | Packaging & Containers | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $419M | $3.35B | $5.10B | $8.43B | $23.04B |
| Revenue (TTM) | $3.29B | $3.28B | $7.49B | $8.64B | $22.48B |
| Net Income (TTM) | $-133M | $158M | $1.04B | $399M | $-774M |
| Gross Margin | 10.0% | 31.7% | 20.9% | 19.8% | -19.3% |
| Operating Margin | 2.9% | 9.3% | 8.7% | 9.4% | -0.9% |
| Forward P/E | 14.9x | 12.0x | 8.8x | 12.5x | 9.9x |
| Total Debt | $2.02B | $1.92B | $4.85B | $5.08B | $15.96B |
| Cash & Equiv. | $305M | $511M | $378M | $566M | $3.45B |
MAGN vs AVNT vs SON vs EMN vs LYB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Magnera Corp. (MAGN) | 100 | 5.9 | -94.1% |
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
| Sonoco Products Com… (SON) | 100 | 99.8 | -0.2% |
| Eastman Chemical Co… (EMN) | 100 | 108.2 | +8.2% |
| LyondellBasell Indu… (LYB) | 100 | 112.1 | +12.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MAGN vs AVNT vs SON vs EMN vs LYB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MAGN is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth 46.5%, EPS growth -1.6%, 3Y rev CAGR 29.0%
- 46.5% revenue growth vs LYB's -25.2%
- 100.0% yield, 1-year raise streak, vs SON's 4.0%
AVNT lags the leaders in this set but could rank higher in a more targeted comparison.
SON carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 0.62 vs EMN's 3.89
- Lower P/E (8.8x vs 9.9x)
- 13.8% margin vs MAGN's -4.0%
- 9.0% ROA vs MAGN's -3.3%, ROIC 6.2% vs 2.1%
Among these 5 stocks, EMN doesn't own a clear edge in any measured category.
LYB ranks third and is worth considering specifically for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.38, yield 7.7%
- 48.6% 10Y total return vs SON's 48.6%
- Lower volatility, beta 0.38, current ratio 1.77x
- Beta 0.38, yield 7.7%, current ratio 1.77x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 46.5% revenue growth vs LYB's -25.2% | |
| Value | Lower P/E (8.8x vs 9.9x) | |
| Quality / Margins | 13.8% margin vs MAGN's -4.0% | |
| Stability / Safety | Beta 0.38 vs MAGN's 1.55, lower leverage | |
| Dividends | 100.0% yield, 1-year raise streak, vs SON's 4.0% | |
| Momentum (1Y) | +37.2% vs MAGN's -5.2% | |
| Efficiency (ROA) | 9.0% ROA vs MAGN's -3.3%, ROIC 6.2% vs 2.1% |
MAGN vs AVNT vs SON vs EMN vs LYB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MAGN vs AVNT vs SON vs EMN vs LYB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AVNT leads in 1 of 6 categories
MAGN leads 1 • SON leads 1 • LYB leads 1 • EMN leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AVNT leads this category, winning 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LYB is the larger business by revenue, generating $22.5B annually — 6.9x AVNT's $3.3B. SON is the more profitable business, keeping 13.8% of every revenue dollar as net income compared to MAGN's -4.0%. On growth, MAGN holds the edge at +12.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.3B | $3.3B | $7.5B | $8.6B | $22.5B |
| EBITDAEarnings before interest/tax | $299M | $445M | $1.2B | $1.2B | $865M |
| Net IncomeAfter-tax profit | -$133M | $158M | $1.0B | $399M | -$774M |
| Free Cash FlowCash after capex | $97M | $205M | $266M | $498M | $3.1B |
| Gross MarginGross profit ÷ Revenue | +10.0% | +31.7% | +20.9% | +19.8% | -19.3% |
| Operating MarginEBIT ÷ Revenue | +2.9% | +9.3% | +8.7% | +9.4% | -0.9% |
| Net MarginNet income ÷ Revenue | -4.0% | +4.8% | +13.8% | +4.6% | -3.4% |
| FCF MarginFCF ÷ Revenue | +2.9% | +6.3% | +3.6% | +5.8% | +13.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +12.8% | +2.5% | -1.9% | -4.9% | -100.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +43.8% | +3.8% | +23.6% | -40.8% | -100.0% |
Valuation Metrics
MAGN leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 13.0x trailing earnings, SON trades at a 68% valuation discount to AVNT's 41.0x P/E. Adjusting for growth (PEG ratio), SON offers better value at 0.92x vs EMN's 5.59x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $419M | $3.3B | $5.1B | $8.4B | $23.0B |
| Enterprise ValueMkt cap + debt − cash | $2.1B | $4.8B | $9.6B | $12.9B | $35.5B |
| Trailing P/EPrice ÷ TTM EPS | -2.63x | 41.01x | 12.99x | 17.97x | -30.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.91x | 11.95x | 8.84x | 12.50x | 9.92x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.92x | 5.59x | — |
| EV / EBITDAEnterprise value multiple | 7.10x | 12.22x | 7.77x | 8.96x | 33.44x |
| Price / SalesMarket cap ÷ Revenue | 0.13x | 1.03x | 0.68x | 0.96x | 0.76x |
| Price / BookPrice ÷ Book value/share | 0.39x | 1.40x | 1.42x | 1.41x | 2.26x |
| Price / FCFMarket cap ÷ FCF | 11.65x | 17.16x | 12.99x | 19.87x | 59.99x |
Profitability & Efficiency
SON leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
SON delivers a 30.0% return on equity — every $100 of shareholder capital generates $30 in annual profit, vs $-12 for MAGN. AVNT carries lower financial leverage with a 0.81x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAGN's 1.89x. On the Piotroski fundamental quality scale (0–9), SON scores 7/9 vs LYB's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -12.3% | +6.6% | +30.0% | +6.7% | -7.2% |
| ROA (TTM)Return on assets | -3.3% | +2.6% | +9.0% | +2.6% | -3.0% |
| ROICReturn on invested capital | +2.1% | +3.9% | +6.2% | +6.7% | -1.1% |
| ROCEReturn on capital employed | +3.3% | +4.0% | +8.3% | +7.5% | -1.1% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 5 | 3 |
| Debt / EquityFinancial leverage | 1.89x | 0.81x | 1.34x | 0.84x | 1.56x |
| Net DebtTotal debt minus cash | $1.7B | $1.4B | $4.5B | $4.5B | $12.5B |
| Cash & Equiv.Liquid assets | $305M | $511M | $378M | $566M | $3.4B |
| Total DebtShort + long-term debt | $2.0B | $1.9B | $4.9B | $5.1B | $16.0B |
| Interest CoverageEBIT ÷ Interest expense | 0.61x | 3.61x | 4.60x | 2.22x | -1.42x |
Total Returns (Dividends Reinvested)
LYB leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in SON five years ago would be worth $9,026 today (with dividends reinvested), compared to $1,050 for MAGN. Over the past 12 months, LYB leads with a +37.2% total return vs MAGN's -5.2%. The 3-year compound annual growth rate (CAGR) favors EMN at 1.1% vs MAGN's -36.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -17.4% | +16.0% | +17.7% | +15.8% | +62.6% |
| 1-Year ReturnPast 12 months | -5.2% | +4.1% | +21.9% | +2.3% | +37.2% |
| 3-Year ReturnCumulative with dividends | -74.5% | +2.3% | -3.2% | +3.4% | -5.5% |
| 5-Year ReturnCumulative with dividends | -89.5% | -22.7% | -9.7% | -28.4% | -11.3% |
| 10-Year ReturnCumulative with dividends | -82.3% | +27.8% | +48.6% | +35.4% | +48.6% |
| CAGR (3Y)Annualised 3-year return | -36.6% | +0.8% | -1.1% | +1.1% | -1.9% |
Risk & Volatility
Evenly matched — SON and LYB each lead in 1 of 2 comparable metrics.
Risk & Volatility
LYB is the less volatile stock with a 0.38 beta — it tends to amplify market swings less than MAGN's 1.55 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SON currently trades 88.5% from its 52-week high vs MAGN's 75.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.55x | 1.19x | 0.53x | 1.36x | 0.38x |
| 52-Week HighHighest price in past year | $15.64 | $44.85 | $58.43 | $84.18 | $83.94 |
| 52-Week LowLowest price in past year | $7.82 | $27.48 | $38.65 | $56.11 | $41.58 |
| % of 52W HighCurrent price vs 52-week peak | +75.3% | +81.4% | +88.5% | +87.5% | +85.2% |
| RSI (14)Momentum oscillator 0–100 | 59.4 | 55.2 | 50.8 | 56.9 | 50.9 |
| Avg Volume (50D)Average daily shares traded | 427K | 620K | 1.1M | 1.5M | 8.1M |
Analyst Outlook
Evenly matched — MAGN and SON each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MAGN as "Hold", AVNT as "Buy", SON as "Buy", EMN as "Buy", LYB as "Hold". Consensus price targets imply 48.6% upside for MAGN (target: $18) vs 2.9% for LYB (target: $74). For income investors, MAGN offers the higher dividend yield at 100.00% vs AVNT's 2.95%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $17.50 | $48.40 | $59.00 | $77.29 | $73.60 |
| # AnalystsCovering analysts | 1 | 20 | 21 | 35 | 39 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +2.9% | +4.0% | +4.5% | +7.7% |
| Dividend StreakConsecutive years of raises | 1 | 14 | 30 | 12 | 2 |
| Dividend / ShareAnnual DPS | $31.30 | $1.08 | $2.09 | $3.30 | $5.48 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.1% | +0.2% | +1.2% | +0.9% |
AVNT leads in 1 of 6 categories (Income & Cash Flow). MAGN leads in 1 (Valuation Metrics). 2 tied.
MAGN vs AVNT vs SON vs EMN vs LYB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MAGN or AVNT or SON or EMN or LYB a better buy right now?
For growth investors, Magnera Corp.
(MAGN) is the stronger pick with 46. 5% revenue growth year-over-year, versus -25. 2% for LyondellBasell Industries N. V. (LYB). Sonoco Products Company (SON) offers the better valuation at 13. 0x trailing P/E (8. 8x forward), making it the more compelling value choice. Analysts rate Avient Corporation (AVNT) a "Buy" — based on 20 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MAGN or AVNT or SON or EMN or LYB?
On trailing P/E, Sonoco Products Company (SON) is the cheapest at 13.
0x versus Avient Corporation at 41. 0x. On forward P/E, Sonoco Products Company is actually cheaper at 8. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Sonoco Products Company wins at 0. 62x versus Eastman Chemical Company's 3. 89x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MAGN or AVNT or SON or EMN or LYB?
Over the past 5 years, Sonoco Products Company (SON) delivered a total return of -9.
7%, compared to -89. 5% for Magnera Corp. (MAGN). Over 10 years, the gap is even starker: LYB returned +48. 6% versus MAGN's -82. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MAGN or AVNT or SON or EMN or LYB?
By beta (market sensitivity over 5 years), LyondellBasell Industries N.
V. (LYB) is the lower-risk stock at 0. 38β versus Magnera Corp. 's 1. 55β — meaning MAGN is approximately 307% more volatile than LYB relative to the S&P 500. On balance sheet safety, Avient Corporation (AVNT) carries a lower debt/equity ratio of 81% versus 189% for Magnera Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — MAGN or AVNT or SON or EMN or LYB?
By revenue growth (latest reported year), Magnera Corp.
(MAGN) is pulling ahead at 46. 5% versus -25. 2% for LyondellBasell Industries N. V. (LYB). On earnings-per-share growth, the picture is similar: Sonoco Products Company grew EPS 141. 2% year-over-year, compared to -156. 6% for LyondellBasell Industries N. V.. Over a 3-year CAGR, MAGN leads at 29. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MAGN or AVNT or SON or EMN or LYB?
Eastman Chemical Company (EMN) is the more profitable company, earning 5.
4% net margin versus -5. 0% for Magnera Corp. — meaning it keeps 5. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMN leads at 10. 6% versus -1. 1% for LYB. At the gross margin level — before operating expenses — AVNT leads at 32. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MAGN or AVNT or SON or EMN or LYB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Sonoco Products Company (SON) is the more undervalued stock at a PEG of 0. 62x versus Eastman Chemical Company's 3. 89x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Sonoco Products Company (SON) trades at 8. 8x forward P/E versus 14. 9x for Magnera Corp. — 6. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MAGN: 48. 6% to $17. 50.
08Which pays a better dividend — MAGN or AVNT or SON or EMN or LYB?
All stocks in this comparison pay dividends.
Magnera Corp. (MAGN) offers the highest yield at 100. 0%, versus 2. 9% for Avient Corporation (AVNT).
09Is MAGN or AVNT or SON or EMN or LYB better for a retirement portfolio?
For long-horizon retirement investors, LyondellBasell Industries N.
V. (LYB) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 38), 7. 7% yield). Magnera Corp. (MAGN) carries a higher beta of 1. 55 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LYB: +48. 6%, MAGN: -82. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MAGN and AVNT and SON and EMN and LYB?
These companies operate in different sectors (MAGN (Industrials) and AVNT (Basic Materials) and SON (Consumer Cyclical) and EMN (Basic Materials) and LYB (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: MAGN is a small-cap high-growth stock; AVNT is a small-cap quality compounder stock; SON is a small-cap high-growth stock; EMN is a small-cap deep-value stock; LYB is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.